Feasibility of Using Tablet-Based Cognitive Screening Tools in India: A Short Review

Feasibility of Using Tablet-Based Cognitive Screening Tools in India: A Short Review

Aparna Sahu (Psyneuronics Pvt. Ltd., Mumbai, India)
Copyright: © 2017 |Pages: 11
DOI: 10.4018/IJCCP.2017010103
OnDemand PDF Download:
$30.00
List Price: $37.50

Abstract

Tablet-based cognitive screening batteries are becoming popular in the West due to the ease of administration on patients and healthy controls, collection of data from large samples, and scoring and reporting of test performances. These tests have garnered positive reception from clinical professionals, researchers, and patients. The article seeks to assess the feasibility of introducing tablet-based screening tests for the Indian population. Potential advantages and concerns on the use of smart technologies for testing are addressed in the light of past and current research.
Article Preview

Literature Review

The last decade or so has witnessed the introduction of mobile devices and tablet computers, and the continued use of these devices by people across the world. Following the increased demand, and their efficiency for regular use, countries such as the USA, UK, Denmark, Japan, have begun standardizing and validating tablet based cognitive screening batteries. Test batteries such as, the Oxford Cognitive Screening- Plus (OCS-Plus), a screening test for dementia (Humphreys, Duta, Montana, Demeyere, McCrory, Rohr, Kahn, Tollman, & Berkman, 2017), the Memory Orientation Screening Test (MOST) for identifying neurocognitive disorders in the elderly (Clionsky & Clionsky, 2014), the self-administered iPad based test on processing speed (Rao, Losinski, Mourany, Schindler, Mamone, Reece, Kemeny, Narayanan, Miller, Bethoux, Bermel, Rudick, & Alberts, 2017) and performance test (MSPT- Rudick, Miller, Bethoux, Rao, Lee, Stough, Reece, Schindler, Mamone, & Alberts, 2014) for multiple sclerosis patients, the Cognitive Assessment at Bedside – iPad version (CABPad) - a cognitive screening device for stroke patients (Willer, Pedersen, Forchhammer, & Christensen, 2016), the Cleveland Clinic Concussion app (C3 app) a mobile app for assessing the neuropsychological condition of sports player on the field following a concussion (Alberts & Linder, 2015), and the iPad version of ACE-III (ACEmobile) for early detection of dementia (Hsieh, Schubert, Hoon, Mioshi, & Hodges, 2013) are now available to clinical and research professionals.

Complete Article List

Search this Journal:
Reset
Open Access Articles: Forthcoming
Volume 2: 2 Issues (2017): 1 Released, 1 Forthcoming
Volume 1: 2 Issues (2016)
View Complete Journal Contents Listing